The NIAID Lab of Clinical Infectious Diseases seeks an enthusiastic & highly motivated clinician to diagnose, treat, and manage patients with GATA2 deficiency and lead clinical protocols relevant to those patient populations. Find out more and apply!

Large increases in #HIV suppression are needed to reduce new infections among men who have sex with men (MSM), according to a new mathematical model based on data from Baltimore presented today at #HIVR4P2016. Researchers performed the modeling as part of a clinical study funded by NIAID and the National Institute of Mental Health that aims to assess an HIV prevention strategy that includes identifying MSM living with HIV who are not virally suppressed, getting them into care, and helping them achieve and maintain viral suppression. Sustained viral suppression is essential both for individual health and to reduce HIV transmission within the community.


Physicians: Gain clinical & translational research experience in the #NIAID Transition Program in Clinical Research. Visit NIAID Careers to learn more about the program and requirements. Closes 11/30.


NIAID seeks talented, motivated, and qualified candidates to serve as scientific review officers. Candidates must be U.S. citizens with excellent written and oral communication skills who have successfully completed all requirements for a Ph.D., D.V.M., M.D., or equivalent doctoral degree. Several positions are open now through 10/12/16. Find out more and apply now!

NIAID's new website so you can quickly find the resources and advice you need. You can then read about NIH's updated policies for application appendix and post-submission materials, find helpful resources on NIH's rigor and reproducibility requirement, and review the latest funding opportunities, requests for information, news briefs, and reader questions! 

NIAID seeks highly motivated and qualified candidates for the Transition Program in Clinical Research (TPCR). TPCR provides an exceptional opportunity for physicians to gain clinical and translational research experience in the NIAID Division of Intramural Research. Visit Careers at NIAID for additional information about the TPCR and how to apply.

In the October 19, 2016 NIAID Funding News, learn how one NIAID-supported small business took advantage of the NIH I-Corps™ Program to sharpen its market strategy, find out what happened at the September Council meeting, and weigh in on a new request for information about interim research projects. Also, read about our latest funding opportunities, policy news, and reader questions, including some helpful information about prior approval for big grants! 

A team led by NIAID scientists has identified a genetic explanation for a syndrome characterized by frustrating and difficult-to-treat symptoms, including skin flushing and itching, gastrointestinal complaints, and joint problems. Identifying this genetic change, which might underlie health issues that affect a substantial number of people, opens the door for future development of potential diagnosis and treatment strategies. 

In the October 5, 2016 NIAID Funding News, read about the new availability of 175,000 cryopreserved germline mutations from Dr. Bruce Beutler, a NIAID-supported Nobel Prize winner, and discover many other resources NIAID provides to save investigators money and time. Then get our advice on how to write a successful Leadership Plan for an application with multiple principal investigators and check out our latest FOAs, policy news, training opportunities, and reader questions!

Check out the new mobile-friendly NIAID Careers website. Visit the “Life at NIAID” section to see what it’s like to work here and to hear testimonials from NIAID employees. Join NIAID and make a difference!

NIAID's Lab of Clinical Infectious Diseases seeks candidates for a staff clinician position in the area of bone marrow transplantation for the treatment of GATA2 deficiency and related immunodeficiency diseases. Find out more and apply now! 

Results from an NIAID-funded study suggest that the composition of microbial communities and the related microbe-associated metabolites in the gut of very young infants contribute to their risk of developing allergies and asthma during childhood. The findings eventually may help advance development of early-life interventions to prevent allergies and allergic diseases.